Circulating Fibroblast Growth Factor 21 (FGF21) as a Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma

Joe R Eid,1 Merih Yalciner,1 Lianchun Xiao,2 Ryan Sun,2 Mahesh Kumar Kannan,3 Manal Hassan,4 Asif Rashid,5 Shadi Chamseddine,6 Hop S Tran Cao,7 Hesham M Amin,3,8 Ahmed O Kaseb1 1Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Dep...

Descripció completa

Dades bibliogràfiques

Autors principals:	Eid JR, Yalciner M, Xiao L, Sun R, Kannan MK, Hassan M, Rashid A, Chamseddine S, Tran Cao HS, Amin HM, Kaseb AO
Format:	Artigo
Idioma:	Inglês
Publicat:	Dove Medical Press 2025-12-01
Col·lecció:	Journal of Hepatocellular Carcinoma
Matèries:	Hepatocellular carcinoma fibroblast growth factor 21 prognostic biomarker overall survival
Accés en línia:	https://www.dovepress.com/circulating-fibroblast-growth-factor-21-fgf21-as-a-prognostic-and-diag-peer-reviewed-fulltext-article-JHC
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!